LysoPC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
|
Basic information |
| Metabolite name | LysoPC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) |
 | HMDB0010404 |
 |
C04230 |
 |
10415542 |
| Synonyms | LysoPC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)) |
| No. of studies | 6 |
|
Basic information |
| Metabolite name | LysoPC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) |
| HMDB0010404 |
|
C04230 |
|
10415542 |
| Synonyms | LysoPC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)) |
| No. of studies | 6 |
|
Relationship between LysoPC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) and depression (count: 6) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M460 | Type1 | depressed group vs. control group | Liver | Kunming mouse | Up |
| Study M572 | Type1 | major antenatal depression group vs. control group | Plasma | Human | Up |
| Study M609 | Type2 | LPS + NBP group vs. LPS group | Hippocampus | Sprague-Dawley rat | Up |
| Study M687 | Type2 | Kai-Xin-San group vs. depression group | Serum | Human | Up |
| Study M690 | Type2 | CUMS + high dose of Zhi-zi-chi decoction group vs. CUMS group | Serum | Balb/c mouse | Up |
| Study M835 | Type1 | CRS group vs. control group | Faece | C57BL/6 mouse | Up |